ICC statement on adverse analytical finding in IPL

The ICC is aware of an adverse analytical finding (AAF) from the recently-concluded Indian Premier League (IPL).

When an AAF arises, the World Anti-Doping Agency (WADA) accredited laboratory that has tested the sample sends a report to the commissioning body (IPL) and copies in WADA and the International Federation, in this case the ICC.

As with any AAF that arises during a testing programme organised by one of the ICC’s Members, it is the responsibility of that Member, in this case the BCCI, to deal with the process in a timely and fair manner.

The ICC is proud of its status as a WADA signatory and will be closely monitoring the situation to ensure the correct action is taken by the BCCI. The ICC retains a right of appeal if any penalty that may be imposed is inconsistent with the WADA Code.